<SEC-DOCUMENT>0001104659-21-130027-index.html : 20211026
<SEC-HEADER>0001104659-21-130027.hdr.sgml : 20211026
<ACCEPTANCE-DATETIME>20211026170214
ACCESSION NUMBER:		0001104659-21-130027
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20211026
FILED AS OF DATE:		20211026
DATE AS OF CHANGE:		20211026

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BAY CITY CAPITAL LLC
		CENTRAL INDEX KEY:			0001288452
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40925
		FILM NUMBER:		211349400

	BUSINESS ADDRESS:	
		STREET 1:		750 BATTERY STREET STE 400
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		415.676.3830

	MAIL ADDRESS:	
		STREET 1:		750 BATTERY STREET STE 400
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111

	FORMER NAME:	
		FORMER CONFORMED NAME:	BAY CITY CAPITAL FUND LLC
		DATE OF NAME CHANGE:	20040423

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Xilio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001840233
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				851623397
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		828 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-833-1027

	MAIL ADDRESS:	
		STREET 1:		828 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2130646-25_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2130646-25_4seq1.html

Document 1 - RAW XML: tm2130646-25_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>